Our data show that adenocarcinomas derived from CD133-positive cells have a high density of tumor cells and poor differentiation compared with tumors resulting from unsorted cells, which mainly consist of nonproliferative fibrinoid components, indicating that tumors derived from CD133-positive ID8 cells have features of recurrent tumors in ovarian cancer patients. Here, PROM1 is linked to adenocarcinoma.